Skip to main content Accessibility help
×
Hostname: page-component-76fb5796d-skm99 Total loading time: 0 Render date: 2024-04-26T08:19:51.249Z Has data issue: false hasContentIssue false

36 - Electroconvulsive Therapy, Brain Stimulation Therapies, and Other Novel Treatments

from PART IV - PSYCHIATRIC THERAPEUTICS

Published online by Cambridge University Press:  18 January 2010

William Weiqi Wang
Affiliation:
St Louis University, Missouri
Get access

Summary

Treating mental illness with physical technologies provides effective alternatives to psychopharmacology. Physical technologies were used before and around the birth of psychopharmacology to bring impact on impaired brain function. Though considered by some to be antiquated, several of these treatments have gone through continuous technical refinement and remain active in mainstay psychiatry. New technologies have been developed in recent years and offered hope for more powerful and safer treatment.

Among the old treatments, the most prominent and publicized one is the electroconvulsive therapy (ECT). ECT is also probably the most controversial treatment in psychiatry. The negative perception of ECT may be traced to its historical stages of crude technology, and further, largely influenced by motion pictures that rarely depicted ECT in reasonable resemblance to modern practice. The use of anesthesia, muscle relaxant, and brief pulse are among the technical advancements that have made ECT a much safer procedure. Research has proved ECT the most effective treatment for major depression, a rapidly effective treatment for a spectrum of life-threatening psychiatric conditions, and under many circumstances a safer option of treatment.

Psychosurgery, though not a brain stimulation therapy, bore similar scrutiny as ECT did, and remains active because of its efficacy in a small group of severe cases.

New developments described here include vagus nerve stimulation and transcranial magnetic stimulation, both are Food and Drug Administration (FDA) approved treatments for depression, and deep brain stimulation, which is FDA approved for treatmentresistant, obsessive-compulsive disorder, and Parkinson's disease.

Cognitive impairment in ECT

  1. ▶ Postictal/postanesthetic confusion

  2. […]

Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2009

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×